Literature DB >> 2193344

Cardiovascular and bacteremic manifestations of Campylobacter fetus infection: case report and review.

V A Morrison1, B K Lloyd, J K Chia, C U Tuazon.   

Abstract

A case of bacteremia due to Campylobacter fetus subspecies fetus with concomitant pleuropericarditis in a previously healthy patient is presented. The organism is ubiquitous, but most commonly causes infection in patients with chronic underlying illnesses. The pathogenesis of human infection has not been definitively elucidated. Bacteremia is the most common clinical manifestation of this infection, although cases of thrombophlebitis, mycotic aneurysm, endocarditis, and pericarditis have also been reported. The treatment of choice for most infections is gentamicin, with chloramphenicol recommended for infection involving the central nervous system. Tetracyclines and erythromycin are alternative agents. Prolonged therapy is essential to the prevention of relapse. A high index of suspicion is necessary for the recognition of this organism in the appropriate clinical settings.

Entities:  

Mesh:

Year:  1990        PMID: 2193344     DOI: 10.1093/clinids/12.3.387

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  20 in total

1.  Campylobacter fetus as cause of prosthetic valve endocarditis.

Authors:  Akiko Haruyama; Shigeru Toyoda; Migaku Kikuchi; Takuo Arikawa; Shu Inami; Naoyuki Otani; Hirohisa Amano; Ryuko Matsuda; Teruo Inoue
Journal:  Tex Heart Inst J       Date:  2011

2.  Epidemiology and antimicrobial susceptibilities of 111 Campylobacter fetus subsp. fetus strains isolated in Québec, Canada, from 1983 to 2000.

Authors:  Carole Tremblay; Christiane Gaudreau; Manon Lorange
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

3.  Steak tartare endocarditis.

Authors:  Michael J A Reid; Evan Michael Shannon; Sanjiv M Baxi; Peter Chin-Hong
Journal:  BMJ Case Rep       Date:  2016-02-25

4.  Antimicrobial susceptibility testing of 59 strains of Campylobacter fetus subsp. fetus.

Authors:  C Tremblay; C Gaudreau
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

Review 5.  Global Epidemiology of Campylobacter Infection.

Authors:  Nadeem O Kaakoush; Natalia Castaño-Rodríguez; Hazel M Mitchell; Si Ming Man
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

Review 6.  Campylobacter surface-layers (S-layers) and immune evasion.

Authors:  Stuart A Thompson
Journal:  Ann Periodontol       Date:  2002-12

7.  Infective abdominal aortitis due to Campylobacter fetus bacteremia: A case report and review of literature.

Authors:  Abhinav Agrawal; Rutuja R Sikachi
Journal:  Intractable Rare Dis Res       Date:  2016-11

8.  Campylobacter fetus bloodstream infection: risk factors and clinical features.

Authors:  L Gazaigne; P Legrand; B Renaud; B Bourra; E Taillandier; C Brun-Buisson; P Lesprit
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-11-13       Impact factor: 3.267

9.  Campylobacter fetus meningitis in a diabetic adult cured by imipenem.

Authors:  J Herve; N Aissa; P Legrand; M Sorkine; M J Calmette; A Santin; E Roupie; B Renaud
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-08-20       Impact factor: 3.267

10.  Uncommon Campylobacter species in infant Macaca nemestrina monkeys housed in a nursery.

Authors:  R G Russell; J A Kiehlbauch; C J Gebhart; L J DeTolla
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.